🔗 Share this article

The prestigious award in medical science has been granted for revolutionary findings that clarify how the immune system attacks harmful infections while sparing the body's own cells.

Three renowned scientists—from Japan Prof. Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—received this honor.

Their work identified specialized "security guards" within the immune system that remove rogue defense cells that could attacking the body.

These discoveries are now enabling innovative treatments for autoimmune diseases and cancer.

These winners will divide a monetary award worth 11 million SEK.

Decisive Findings

"The research has been essential for comprehending how the body's defenses functions and why we don't all develop serious self-attack conditions," commented the head of the award panel.

This trio's studies address a core mystery: How does the defense system defend us from countless invaders while leaving our healthy cells unharmed?

Our body's protection system employs immune cells that search for indicators of infection, including pathogens and bacteria it has not met before.

These cells employ detectors—called recognition units—that are generated by chance in a vast number of variations.

This provides the defense network the ability to combat a broad range of invaders, but the randomness of the process unavoidably creates immune cells that can target the body.

Security Guards of the Immune System

Researchers earlier knew that some of these harmful defense cells were destroyed in the immune organ—where white blood cells mature.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—known as the immune system's "security guards"—which patrol the system to disarm other defenders that attack the healthy cells.

We know that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

The Nobel panel stated, "These findings have established a novel area of investigation and spurred the development of new treatments, for instance for cancer and autoimmune diseases."

Regarding malignancies, regulatory T-cells prevent the system from attacking the growth, so research are focused on reducing their quantity.

In self-attack disorders, trials are exploring increasing T-reg cells so the organism is no longer under attack. A comparable method could also be effective in reducing the chances of transplanted organ failure.

Pioneering Experiments

Professor Shimon Sakaguchi, of Osaka University, performed experiments on rodents that had their immune gland removed, causing autoimmune disease.

The researcher demonstrated that introducing immune cells from healthy animals could stop the illness—implying there was a system for blocking defenders from attacking the host.

Mary Brunkow, from the a research center in Seattle, and Fred Ramsdell, currently at a biotech firm in San Francisco, were studying an genetic immune disorder in mice and humans that led to the discovery of a genetic factor critical for the way regulatory T-cells function.

"Their groundbreaking research has revealed how the body's defenses is controlled by regulatory T cells, preventing it from mistakenly attacking the body's own tissues," commented a leading biological science expert.

"This research is a remarkable illustration of how fundamental biological study can have far-reaching implications for public health."